Tech Company Financing Transactions
Gameto Funding Round
On 9/14/2022, Gameto raised $17 million in investment from Arcadian Partners, Bold Capital Partners and Future Ventures.
Transaction Overview
Company Name
Announced On
9/14/2022
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Gameto's underlying cell engineering platform was developed in stealth under a scientific research agreement with George Church's lab at Harvard Medical School. In January, Gameto announced plans for three sequenced programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
515 Madison Ave 8th fl
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Undisclosed
Website
Email Address
Overview
Operator of a biotechnology company intended to solve diseases of the female reproductive system. The company's platform uses proprietary combinations of transcription factors to generate engineered ovarian cell lines that mimic the functions of endogenous cells, producing and responding to all hormones, enabling women to solve the problem of accelerated ovarian aging.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Martin Varsavsky
Chief Executive Officer
Dina Radenkovic
VP - Finance
Milos Fulton
Browse more venture capital transactions:
Prev: 9/14/2022: Chameleon venture capital transaction
Next: 9/14/2022: Prolific Machines venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs